Difficulty: Medium
Average Score: 95%
Practice
The dose of digoxin in congestive heart failure is adjusted by monitoring
Correct answer
D
Rationale
In the management of congestive heart failure (CHF) with digoxin, monitoring the plasma digoxin levels is crucial for adjusting the dosage effectively. The correct answer is D) Plasma digoxin levels. This is because digoxin has a narrow therapeutic range, meaning that levels must be carefully monitored to ensure efficacy and prevent toxicity. By measuring the plasma digoxin levels, healthcare providers can determine if the drug is within the desired therapeutic range.
Option A) Electrocardiogram is not the primary method for adjusting digoxin dosage in CHF. While an ECG can provide valuable information about the heart's electrical activity, it does not directly measure digoxin levels.
Option B) Monitoring heart rate and symptoms of CHF can help assess the patient's response to digoxin therapy, but it does not provide specific information about digoxin levels in the body.
Option C) Blood pressure monitoring is important in the management of CHF but is not the most direct method for adjusting digoxin dosage. Blood pressure monitoring helps assess the overall cardiovascular status of the patient but does not reflect digoxin levels.
In an educational context, understanding the rationale behind monitoring plasma digoxin levels in CHF patients is essential for nursing students and healthcare professionals. It emphasizes the importance of individualizing medication dosages based on therapeutic drug monitoring to optimize patient outcomes and minimize the risk of adverse effects. By grasping this concept, students can apply critical thinking skills in medication management and provide safe, evidence-based care to patients with CHF.
Option A) Electrocardiogram is not the primary method for adjusting digoxin dosage in CHF. While an ECG can provide valuable information about the heart's electrical activity, it does not directly measure digoxin levels.
Option B) Monitoring heart rate and symptoms of CHF can help assess the patient's response to digoxin therapy, but it does not provide specific information about digoxin levels in the body.
Option C) Blood pressure monitoring is important in the management of CHF but is not the most direct method for adjusting digoxin dosage. Blood pressure monitoring helps assess the overall cardiovascular status of the patient but does not reflect digoxin levels.
In an educational context, understanding the rationale behind monitoring plasma digoxin levels in CHF patients is essential for nursing students and healthcare professionals. It emphasizes the importance of individualizing medication dosages based on therapeutic drug monitoring to optimize patient outcomes and minimize the risk of adverse effects. By grasping this concept, students can apply critical thinking skills in medication management and provide safe, evidence-based care to patients with CHF.